First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)
Clinical trial NCT04733027 · COMPLETED
Trial details
- NCT number
- NCT04733027
- Sponsor
- Institut Curie
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-18
- Primary completion
- 2026-06-11
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.